Showing 1 - 1 of 1
The costs associated with the care of Alzheimer’s disease patients are very high, particularly those associated with nursing home placement. The combination of a cholinesterase inhibitor (ChEI) and memantine has been shown to significantly delay admission to nursing homes as compared to...
Persistent link: https://www.econbiz.de/10011151226